BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23962110)

  • 1. The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
    Kchour G; Rezaee R; Farid R; Ghantous A; Rafatpanah H; Tarhini M; Kooshyar MM; El Hajj H; Berry F; Mortada M; Nasser R; Shirdel A; Dassouki Z; Ezzedine M; Rahimi H; Ghavamzadeh A; de Thé H; Hermine O; Mahmoudi M; Bazarbachi A
    Retrovirology; 2013 Aug; 10():91. PubMed ID: 23962110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
    Kchour G; Tarhini M; Kooshyar MM; El Hajj H; Wattel E; Mahmoudi M; Hatoum H; Rahimi H; Maleki M; Rafatpanah H; Rezaee SA; Yazdi MT; Shirdel A; de Thé H; Hermine O; Farid R; Bazarbachi A
    Blood; 2009 Jun; 113(26):6528-32. PubMed ID: 19411628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
    Hermine O; Dombret H; Poupon J; Arnulf B; Lefrère F; Rousselot P; Damaj G; Delarue R; Fermand JP; Brouet JC; Degos L; Varet B; de Thé H; Bazarbachi A
    Hematol J; 2004; 5(2):130-4. PubMed ID: 15048063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How I treat adult T-cell leukemia/lymphoma.
    Bazarbachi A; Suarez F; Fields P; Hermine O
    Blood; 2011 Aug; 118(7):1736-45. PubMed ID: 21673346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha.
    Mahieux R; Hermine O
    Leuk Lymphoma; 2005 Mar; 46(3):347-55. PubMed ID: 15621824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
    Hermine O; Allard I; Lévy V; Arnulf B; Gessain A; Bazarbachi A;
    Hematol J; 2002; 3(6):276-82. PubMed ID: 12522449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
    Bazarbachi A; Hermine O
    Virus Res; 2001 Oct; 78(1-2):79-92. PubMed ID: 11520582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma.
    Nasr R; Marçais A; Hermine O; Bazarbachi A
    Methods Mol Biol; 2017; 1582():197-216. PubMed ID: 28357672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide (As
    Marçais A; Cook L; Witkover A; Asnafi V; Avettand-Fenoel V; Delarue R; Cheminant M; Sibon D; Frenzel L; de Thé H; Bangham CRM; Bazarbachi A; Hermine O; Suarez F
    Retrovirology; 2020 Mar; 17(1):5. PubMed ID: 32199462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of arsenic trioxide with or without interferon-alpha for relapsed/refractory adult T-cell leukemia/lymphoma.
    Ishitsuka K; Suzumiya J; Aoki M; Ogata K; Hara S; Tamura K
    Haematologica; 2007 May; 92(5):719-20. PubMed ID: 17488707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
    Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A
    Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1.
    Brown M; Bellon M; Nicot C
    Blood; 2007 Feb; 109(4):1653-9. PubMed ID: 17077332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.
    Cook LB; Rowan AG; Demontis MA; Sagawe S; Gillet NA; Melamed A; Greiller C; Witkover A; Bangham CRM; Taylor GP
    Int J Hematol; 2018 Mar; 107(3):378-382. PubMed ID: 29090417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
    Guery R; Suarez F; Lanternier F; Bougnoux ME; Lecuyer H; Avettand-Fenoel V; Sibon D; Frenzel L; Raphalen JH; Helias P; Renaudier P; Santa F; Lecuit M; Lortholary O; Hermine O; Aguilar C; Marçais A
    Ann Hematol; 2021 Nov; 100(11):2813-2824. PubMed ID: 34387741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells.
    Nasr R; Rosenwald A; El-Sabban ME; Arnulf B; Zalloua P; Lepelletier Y; Bex F; Hermine O; Staudt L; de Thé H; Bazarbachi A
    Blood; 2003 Jun; 101(11):4576-82. PubMed ID: 12560223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus).
    Heraud JM; Mortreux F; Merien F; Contamin H; Mahieux R; Pouliquen JF; Wattel E; Gessain A; de Thé H; Bazarbachi A; Hermine O; Kazanji M
    Antiviral Res; 2006 Jul; 70(3):132-9. PubMed ID: 16540180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma.
    Bazarbachi A; Nasr R; El-Sabban ME; Mahé A; Mahieux R; Gessain A; Darwiche N; Dbaibo G; Kersual J; Zermati Y; Dianoux L; Chelbi-Alix MK; de Thé H; Hermine O
    Leukemia; 2000 Apr; 14(4):716-21. PubMed ID: 10764160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma.
    White JD; Wharfe G; Stewart DM; Maher VE; Eicher D; Herring B; Derby M; Jackson-Booth PG; Marshall M; Lucy D; Jain A; Cranston B; Hanchard B; Lee CC; Top LE; Fleisher TA; Nelson DL; Waldmann TA
    Leuk Lymphoma; 2001 Jan; 40(3-4):287-94. PubMed ID: 11426550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
    Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
    J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia.
    El Hajj H; El-Sabban M; Hasegawa H; Zaatari G; Ablain J; Saab ST; Janin A; Mahfouz R; Nasr R; Kfoury Y; Nicot C; Hermine O; Hall W; de Thé H; Bazarbachi A
    J Exp Med; 2010 Dec; 207(13):2785-92. PubMed ID: 21135137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.